NCT03913559 2026-02-12Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic LeukemiaSt. Jude Children's Research HospitalPhase 2 Terminated5 enrolled
NCT00004192 2023-12-27Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaUniversity of NebraskaPhase 2 Completed60 enrolled
NCT01093586 2019-01-23Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 2 Completed14 enrolled 22 charts
NCT01177371 2010-08-09High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase 2 Completed13 enrolled